Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Transdermal Lisuride for Restless Legs Syndrome
NCT00367822Phase 3Completed
- Sponsor
- Axxonis Pharma AG
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of lisuride in restless legs syndrome (RLS), sponsored by Axxonis Pharma AG. Status: completed.
02
Drugs
lisuride
03
Conditions
restless legs syndrome (RLS)
Beyond the preview
Go deeper on NCT00367822.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00367822.